Literature DB >> 14976066

Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency.

Seah H Lim, Yana Zhang, Zhiqing Wang, Rupashree Varadarajan, Phillip Periman, W Vance Esler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14976066     DOI： 10.1182/blood-2003-12-4331

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.

Authors:  Teresa Paíno; Enrique M Ocio; Bruno Paiva; Laura San-Segundo; Mercedes Garayoa; Norma C Gutiérrez; M Eugenia Sarasquete; Atanasio Pandiella; Alberto Orfao; Jesús F San Miguel
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.

Authors:  Helena Marco; Rona M Smith; Rachel B Jones; Mary-Jane Guerry; Fausta Catapano; Stella Burns; Afzal N Chaudhry; Kenneth G C Smith; David R W Jayne
Journal:  BMC Musculoskelet Disord       Date:  2014-05-25       Impact factor: 2.362

3.  Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.

Authors:  Venkat Reddy; Lina Martinez; David A Isenberg; Maria J Leandro; Geraldine Cambridge
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.